课题基金 / 基金详情

PH-SENSITIVE HYDROGELS FOR DRUG RELEASE

PH-SENSITIVE HYDROGELS FOR DRUG RELEASE
用于药物释放的 PH 敏感水凝胶
批准号:
3302400
负责人:
NICHOLAS A PEPPAS
金额:
$9.15万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1989
资助国家:
美国
项目状态:
已结题
起止时间:
1989-12-01 至 1992-11-30

项目摘要

项目成果

NICHOLAS A PEPPAS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Development of guidelines for the design of pH-sensitive, swelling- controlled release systems for delivery of drugs, bimolecules and genetically-engineered molecules is investigated. The novel systems are produced from hydrophilic, ionic, glassy polymers which can swell in water or biological fluids. Mechanisms of water-soluble solute diffusion through initially glassy, continuously swelling hydrophilic polymer systems are investigated. Experimental studies are performed with crosslinked copolymers of 2-hydroxyethyl methacrylate with methacrylic acid, N-vinyl- pyrrolidone and various acrylamides using several solutes of low or high molecular weight. The effect of degree of crosslinking and dynamic swelling behavior of the polymer on solute diffusion are studied with a combination of diffusion/dissolution/microtoming/microscopy/stress relaxation experiments. The mesh size is determined experimentally by equilibrium swelling studies. Models are developed for the pH sensitivity of the degree of swelling and the dynamic swelling of these hydrogels.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Decoupling Hydrogel Stiffness and Diffusivity for Hematopoietic Stem Cell Culture and Differentiation
  • 批准号:
    10647478
  • 项目类别:
  • 资助金额:
    $22.21万
  • 财政年份:
    2023
  • 负责人:
    NICHOLAS A PEPPAS
  • 依托单位:
Thermally Responsive Magnetic-Hydrogel Nanocomposites for Advanced Drug Delivery
  • 批准号:
    8339884
  • 项目类别:
  • 资助金额:
    $18.08万
  • 财政年份:
    2011
  • 负责人:
    NICHOLAS A PEPPAS
  • 依托单位:
Thermally Responsive Magnetic-Hydrogel Nanocomposites for Advanced Drug Delivery
  • 批准号:
    8242598
  • 项目类别:
  • 资助金额:
    $21.21万
  • 财政年份:
    2011
  • 负责人:
    NICHOLAS A PEPPAS
  • 依托单位:
Study of he Biophysical Mechanisms Regulating the Efficacy of Orally Administered
海外基金